Septerna (SEPN) Total Current Liabilities (2023 - 2026)
Septerna's quarterly Total Current Liabilities came in at $78.2 million in Q1 2026, up 634.77% year-on-year from $10.6 million in Q1 2025, and down 10.08% quarter-over-quarter from $86.9 million in Q4 2025.
Septerna has reported Total Current Liabilities for 4 years, with the latest figure at $78.2 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 634.77% year-over-year to $78.2 million; the trailing twelve-month figure through Mar 2026 stood at $78.2 million (up 634.77% YoY), and the FY2025 full-year result was $86.9 million, up 576.56% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $78.2 million, down from $86.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $86.9 million in Q4 2025, with the low at $6.9 million in Q4 2023.
- Average Total Current Liabilities over 4 years is $37.4 million, with a median of $14.2 million recorded in 2024.
- Year-over-year, Total Current Liabilities surged 85.84% in 2024 and soared 634.77% in 2026.
- Tracing SEPN's Total Current Liabilities over 4 years: stood at $6.9 million in 2023, then surged by 85.84% to $12.8 million in 2024, then jumped by 576.56% to $86.9 million in 2025, then retreated by 10.08% to $78.2 million in 2026.
- The last three Total Current Liabilities figures came in at $78.2 million (Q1 2026), $86.9 million (Q4 2025), and $75.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.70 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 636.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 66.94 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 13.42 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 3.88 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 5.11 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.35 Bn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - | 78.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.17 Mn |
| Dec 31, 2025 | 86.93 Mn |
| Sep 30, 2025 | 75.28 Mn |
| Jun 30, 2025 | 15.13 Mn |
| Mar 31, 2025 | 10.64 Mn |
| Dec 31, 2024 | 12.85 Mn |
| Sep 30, 2024 | 13.23 Mn |
| Dec 31, 2023 | 6.91 Mn |